Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Fluorine F-18 PARP Inhibitor PET/CT in Diagnosing Patients with Head and Neck Squamous Cell Cancer

Trial Status: closed to accrual

This phase II trial studies the side effects of fluorine F-18 PARP inhibitor in detecting head and neck squamous cell cancer in patients undergoing treatment. Fluorine F-18 PARP inhibitor is a radioactive tracer agent used with positron emission tomography (PET)/computed tomography (CT) scans that may help to find and diagnose tumors in patients with head and neck squamous cell cancer.